Oncology Institute, Inc. 8-K

What Happened

• Oncology Institute, Inc. (the “Company”) filed a Current Report on Form 8-K on March 13, 2026 disclosing that it has prepared an investor presentation for use in meetings with investors.
• The investor presentation is furnished as Exhibit 99.1 to the Form 8-K and the disclosure was made under Item 7.01 (Regulation FD Disclosure).

Key Details

• Exhibit 99.1: Investor Presentation dated March 13, 2026 was furnished with the filing.
• The Form 8-K reports Item 7.01 (Regulation FD Disclosure) and Item 9.01 (exhibits) only.
• No financial statements, earnings, executive changes, mergers, or other material events were reported in this filing.

Why It Matters

• The furnished investor presentation is the company’s current messaging tool for investors and may include updated operational or financial highlights; investors should review it for any new disclosures.
• Filing under Regulation FD signals the company is providing the presentation to ensure broader, fair access to information shared in investor meetings.